Bristol-Myers Squibb reported two Phase 3 trial successes (RYZ101 and admilparant) but saw most gains erased as markets ...
A brief research report found that Medicare beneficiaries taking several commonly prescribed medications could see ...
For Kathryn Branham, the cost of a blood thinner she and her terminally ill husband both take could jump by hundreds of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results